Alan Carr Recent News
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity
Needham Incrementally Bullish On Cara Therapeutics After CR845 Meets Endpoints
2 Reasons Vertex Pharmaceuticals Just Got Upgraded
Analysts Positive On Intercept Pharmaceuticals After Earnings, Pipeline Update
JMP, Needham Doubtful Over Chelsea Therapeutics Receiving Additional Bids
ISIS Pharmaceuticals, Inc. (ISIS) Maintains A Buy Rating